TEST BANK for Pharmacotherapeutics for Advanced Practice Nurse Prescribers 5th Edition by Teri Moser Woo, Marylou V. Robinson. ISBN:% COMPLETE GUIDE for A+ GRADE ASSURED !! CHECK OUT!!!

Pharmacotherapeutics for Advanced Practice Nurse Prescribers 5th Edition Woo Robinson Test Bank
gi gi gi gi gi gi gi gi gi gi gi

, Pharmacotherapeutics for Advanced Practice Nurse Prescribers 5th Edition Woo Robinson Test Bank gi gi gi gi gi gi gi gi gi gi gi




Pharmacotherapeutics
For Advanced Practice Nurse Prescribers 5th Edition Woo Robinson Test Bank


Chapter 1. The Role of the Nurse Practitioner
gi gi gi gi gi gi gi gi




Multiple Choice gi




Identify the choice that best completes the statement or answers the question.
gi gi gi gi gi gi gi gi gi gi gi




gi gig i 1. Nurse practitioner prescriptive authority is regulated by:
gi gi gi gi gi gi gi



1. The National Council of State Boards of Nursing
gi gi gi gi gi gi gi



2. The U.S. Drug Enforcement Administration gi gi gi gi



3. The State Board of Nursing for each state gi gi gi gi gi gi gi



4. The State Board of Pharmacy gi gi gi gi




gi


2. The benefits to the patient of having an Advanced Practice Registered Nurse (APRN) prescr
gig i gi gi gi gi gi gi gi gi gi gi gi gi gi gi



iberinclude: gi



1. Nurses know more about Pharmacology than other prescribers because they take itb
gi gi gi gi gi gi gi gi gi gi gi gi



oth in their basic nursing program and in their APRN program.
gi gi gi gi gi gi gi gi gi gi



2. Nurses care for the patient from a holistic approach and include the patient in
gi gi gi gi gi gi gi gi gi gi gi gi gi



decision making regarding their care. gi gi gi gi



3. APRNs are less likely to prescribe narcotics and other controlled substances.
gi gi gi gi gi gi gi gi gi gi



4. APRNs are able to prescribe independently in all states, whereas a physician’sas
gi gi gi gi gi gi gi gi gi gi gi gi



sistant needs to have a physician supervising their practice.
gi gi gi gi gi gi gi gi




gi gig i 3. Clinical judgment in prescribing includes:
gi gi gi gi gi



1. Factoring in the cost to the patient of the medication prescribed gi gi gi gi gi gi gi gi gi gi



2. Always prescribing the newest medication available for the disease process
gi gi gi gi gi gi gi gi gi



3. Handing out drug samples to poor patients gi gi gi gi gi gi



4. Prescribing all generic medications to cut costs gi gi gi gi gi gi




gi gig i 4. Criteria for choosing an effective drug for a disorder include:
gi gi gi gi gi gi gi gi gi gi



1. Asking the patient what drug they think would work best for themgi gi gi gi gi gi gi gi gi gi gi



2. Consulting nationally recognized guidelines for disease management gi gi gi gi gi gi



3. Prescribing medications that are available as samples before writing a prescription gi gi gi gi gi gi gi gi gi gi



4. Following U.S. Drug Enforcement Administration guidelines for prescribing gi gi gi gi gi gi gi




gi gig i 5. Nurse practitioner practice may thrive under health-care reform because of:
gi gi gi gi gi gi gi gi gi gi



1. The demonstrated ability of nurse practitioners to control costs and improve patiento
gi gi gi gi gi gi gi gi gi gi gi gi



utcomes
2. The fact that nurse practitioners will be able to practice independently
gi gi gi gi gi gi gi gi gi gi



3. The fact that nurse practitioners will have full reimbursement under health-
gi gi gi gi gi gi gi gi gi gi



carereform gi



4. The ability to shift accountability for Medicaid to the state level
gi gi gi gi gi gi gi gi gi gi

,Pharmacotherapeutics for Advanced Practice Nurse Prescribers 5th Edition Woo Robinson Test Bank
gi gi gi gi gi gi gi gi gi gi gi

, Pharmacotherapeutics for Advanced Practice Nurse Prescribers 5th Edition Woo Robinson Test Bank gi gi gi gi gi gi gi gi gi gi gi




Chapter 1. The Role of the Nurse Practitioner
gi gi gi gi gi gi gi gi



Answer Section gi




MULTIPLE CHOICE gi




1. ANS: gigig i 3 PTS: g i 1
2. ANS: gigig i 2 PTS: g i 1
3. ANS: gigig i 1 PTS: g i 1
4. ANS: gigig i 2 PTS: g i 1
5. ANS: gigig i 1 PTS: g i 1

Chapter 2. Review of Basic Principles of Pharmacology
gi gi gi gi gi gi gi gi




Multiple Choice gi




Identify the choice that best completes the statement or answers the question.
gi gi gi gi gi gi gi gi gi gi gi




gi


1. A patient’s nutritional intake and laboratory results reflect hypoalbuminemia. This is critic
gig i gi gi gi gi gi gi gi gi gi gi gi gi



al toprescribing because:
gi gi gi



1. Distribution of drugs to target tissue may be affected. gi gi gi gi gi gi gi gi



2. The solubility of the drug will not match the site of absorption.
gi gi gi gi gi gi gi gi gi gi gi



3. There will be less free drug available to generate an effect.
gi gi gi gi gi gi gi gi gi gi



4. Drugs bound to albumin are readily excreted by the kidneys.
gi gi gi gi gi gi gi gi gi




gi gig i 2. Drugs that have a significant first-pass effect:
gi gi gi gi gi gi gi



1. Must be given by the enteral (oral) route only gi gi gi gi gi gi gi gi



2. Bypass the hepatic circulation gi gi gi



3. Are rapidly metabolized by the liver and may have little if any desired action
gi gi gi gi gi gi gi gi gi gi gi gi gi



4. Are converted by the liver to more active and fat-soluble forms
gi gi gi gi gi gi gi gi gi gi




gi gig i 3. The route of excretion of a volatile drug will likely be the:
gi gi gi gi gi gi gi gi gi gi gi gi



1. Kidneys
2. Lungs
3. Bile and feces gi gi



4. Skin
gi


4. Medroxyprogesterone (Depo Provera) is prescribed intramuscularly (IM) to create a sto
gig i gi gi gi gi gi gi gi gi gi gi gi



ragereservoir of the drug. Storage reservoirs:
gi gi gi gi gi gi



1. Assure that the drug will reach its intended target tissue
gi gi gi gi gi gi gi gi gi



2. Are the reason for giving loading doses
gi gi gi gi gi gi



3. Increase the length of time a drug is available and active gi gi gi gi gi gi gi gi gi gi



4. Are most common in collagen tissues gi gi gi gi gi




gi gig i 5. The NP chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
gi gi gi gi gi gi gi gi gi gi gi gi gi gi gi



1. Propensity to go to the target receptor gi gi gi gi gi gi



2. Biological half-life gi



3. Pharmacodynamics
4. Safety and side effects gi gi gi